🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

Mesa Laboratories, Inc. MLAB R2K

Technology · Scientific & Technical Instruments · United States
https://www.mesalabs.com

Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides testing and laboratory services to the dental and pharmaceutical industries. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for inherited genetic disease testing, pharmacogenetics, oncology testing, infectious disease testing, doping and toxicology testing, and other differentiated applications for use in research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; PurePep Chorus and Symphony instruments for peptide synthesis; and PurePep EasyClean products for purifying peptides. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as environmental and process monitoring, dialysis, gas flow, air quality, and torque testing in medical device and pharmaceutical manufacturing, laboratory, and hospital environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems under DialyGuard, ViewPoint, DataTrace, DryCal, and BGI brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.

READ MORE ›
$102.02
+2.16% 1Y

Market & Price

Market Cap
$563.64M
Current Price
$102.02
High / Low (52W)
$108.94 / $57.01
Beta
0.94

Valuation

Stock P/E
84.31
Industry PE
32.74
Forward P/E
18.93
PEG Ratio
-
Book Value
$33.79
Price to Book
3.02
P/S
2.26
EV/EBITDA
12.87
Dividend Yield
0.63%

Profitability & Returns

ROCE
6.62%
ROE
3.88%
ROA
2.69%
Profit Margin
2.69%
Op Margin
4.31%
EPS (Latest Qtr)
$-0.75
EPS (TTM)
$1.21

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
-
Debt
$0
Total Assets
$433.35M
Current Assets
$102.69M
Working Capital
$-61.28M

Ownership

Promoter Holding
5.44%
Chg in Prom Hold
-
FII / Inst Holding
93.52%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
$538.67M
Total Revenue (TTM)
$249.13M
EBITDA
$41.87M
Free Cash Flow
-
Operating Cash Flow
-
Shares Outstanding
5.52M
Gross Margin
63.53%
Payout Ratio
52.89%

Growth (CAGR)

Revenue 5Y
9.34%
Profit 5Y
-68.50%
Revenue (YoY)
2.60%
Earnings (YoY)
-

PROS

  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Trading at a high P/E of 84.3.
  • Earnings shrank at -68.5% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

Price Chart

Robinhood TradingView StockAnalysis

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Technology).

#NameCMP $P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 MLAB Mesa Laboratories, Inc. R2K 102.02 84.31 $563.64M 0.63% 6.62% 3.88% 9.34% -68.50%
2 NVDA NVIDIA Corporation NDXSPXAI 211.14 32.38 $5.11T 0.47% 81.14% 114.29% 100.05% 201.80%
3 AAPL Apple Inc. NDXSPX 312.06 37.73 $4.58T 0.35% 68.72% 141.47% 1.81% 3.92%
4 MSFT Microsoft Corporation NDXSPXAI 450.24 26.82 $3.34T 0.81% 26.37% 34.01% 12.42% 11.87%
5 TSM Taiwan Semiconductor Manufacturing Company Limited AI 418.45 35.86 $2.17T 0.91% 32.04% 36.21% 18.94% 19.57%
6 MU Micron Technology, Inc. NDXSPXAI 971.00 45.87 $1.10T 0.06% 14.20% 39.82% 6.71% -0.57%
7 AMD Advanced Micro Devices, Inc. NDXSPXAI 516.10 172.61 $841.55B - 6.33% 8.06% 13.64% 48.64%
8 ORCL Oracle Corporation SPXAI 225.78 40.46 $649.35B 0.89% 13.07% 57.57% 10.59% 22.81%
9 ASML ASML Holding N.V. NDXAI 1,612.76 53.76 $621.59B 0.54% 43.81% 52.24% 15.55% 19.55%
Ad space

Quarterly Results

Figures in USD.

Metric Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Jun 2022Sep 2022Dec 2022Jun 2023Sep 2023Dec 2023Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue -----------25.14M24.86M26.68M-26.29M25.54M31.66M-29.94M31.86M34.17M-34.92M35.84M54.70M50.45M58.75M54.29M50.65M53.16M53.47M58.17M57.83M62.84M62.13M59.54M60.74M65.13M-
Cost of Revenue ----------------------------------23.09M23.72M22.60M23.41M23.33M-
Gross Profit 13.07M12.21M15.00M12.01M13.72M13.54M13.96M12.67M13.23M12.68M16.03M15.09M14.58M15.63M15.61M16.20M15.59M14.80M18.77M20.34M21.29M20.65M24.74M22.21M23.14M28.63M31.34M36.39M32.77M31.18M32.11M33.40M37.25M35.45M39.75M38.41M36.94M37.33M41.80M-
Operating Expenses ----------------------------------33.98M36.94M33.88M32.61M33.82M-
Operating Income 3.01M3.83M-2.58M4.01M4.39M-1.98M3.65M-10.09M-4.76M1.14M1.32M-5.39M4.69M-3.25M-3.57M4.47M22.00K-3.12M4.20M-2.51M-4.59M4.00M3.40M-664.00K-60.00K-67.00K5.58M3.51M5.78M1.47M3.06M4.72M7.97M-
EBITDA ----------------------------------6.12M10.48M15.17M10.71M13.35M-
Interest Expense ----------------------------------2.84M2.52M2.20M2.86M3.04M-
Pretax Income -----------------------------------2.22M461.00K7.01M2.00M4.60M-
Tax Provision -----------------------------------541.00K7.58M2.27M-477.00K966.00K-
Net Income -------1.52M2.35M--4.23M994.00K------1.22M2.68M-4.54M-2.00M3.72M-2.06M-1.44M1.31M451.00K-549.00K-1.23M2.12M3.39M3.43M-1.68M-7.11M4.74M2.48M3.63M-
Diluted EPS 0.480.69-0.510.620.84-0.390.60-2.931.081.060.250.210.341.140.73-1.03-0.370.260.51-0.890.740.380.70-0.39-0.270.240.08-0.10-0.230.390.620.63--1.310.850.450.65-0.75
R&D Expense 991.00K975.00K-1.03M1.04M861.00K-1.15M885.00K752.00K-837.00K842.00K860.00K-1.02M915.00K2.11M-2.60M2.41M2.71M-2.81M2.61M5.16M5.70M4.99M4.80M4.81M4.99M4.29M4.74M4.63M5.05M-4.98M5.05M5.03M-

Profit & Loss (Annual)

Figures in USD.

Metric Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue ------93.67M96.18M103.14M117.69M133.94M184.34M219.08M216.19M240.98M
Cost of Revenue -----------75.25M85.39M82.94M90.11M
Gross Profit 19.57M23.51M28.86M31.69M43.39M51.41M53.24M54.62M60.92M65.36M87.01M109.09M133.69M133.25M150.87M
Operating Expenses -----------104.39M130.37M130.79M134.53M
Operating Income 9.86M12.48M13.10M11.79M15.86M16.32M16.31M2.18M9.78M7.92M12.36M4.70M3.32M2.46M16.34M
EBITDA -----------32.53M37.52M-238.38M42.35M
Interest Expense -----------3.88M4.77M5.70M11.86M
Pretax Income -----------3.57M-389.00K-275.65M5.96M
Tax Provision -----------1.70M-1.32M-21.40M7.93M
Net Income ----------3.27M1.87M930.00K-254.25M-1.97M
Diluted EPS 1.862.292.352.492.632.972.91-0.791.860.410.640.350.17-47.20-0.36
R&D Expense 1.44M1.36M2.01M2.32M3.29M3.97M4.16M3.54M3.51M6.36M10.39M15.77M20.49M19.30M19.52M

Compounded Sales Growth

5 Years:9.34%
1 Year:2.60%

Compounded Profit Growth

5 Years:-68.50%
1 Year:-

Stock Price Performance

1 Year:+2.16%
6 Months:+26.34%
3 Months:+5.81%
1 Month:+6.70%

Balance Sheet (Annual)

Figures in USD.

Metric Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets -50.56M50.70M65.92M97.53M117.32M160.75M171.73M164.10M156.77M409.11M601.48M707.37M661.83M446.80M433.35M
Current Assets ------------124.32M118.97M109.35M102.69M
Cash & Equivalents 10.47M3.55M7.19M4.01M5.58M2.03M5.70M5.82M5.47M10.19M81.38M263.87M49.35M32.91M28.21M27.32M
Inventory ------------24.61M34.64M32.67M25.36M
Receivables ------------41.22M42.55M39.05M41.97M
Total Liabilities -14.14M6.78M13.17M33.20M43.84M76.07M73.91M64.74M45.46M189.09M195.25M313.57M268.35M301.40M273.52M
Current Liabilities -9.93M4.26M4.66M10.21M14.66M23.97M16.57M17.29M23.66M26.01M32.58M48.05M43.36M44.31M163.96M
Long Term Debt -1.50M-4.00M16.50M23.25M42.25M53.67M44.63M20.61M--218.37M183.27M221.70M76.90M
Total Debt ------------221.13M186.14M224.68M181.47M
Total Equity 31.20M36.42M43.91M52.75M64.33M73.48M84.68M97.82M99.36M111.31M220.01M406.23M393.80M393.48M145.39M159.83M
Shares Outstanding ------------5.27M5.37M5.39M5.46M

Cash Flows (Annual)

Figures in USD.

Metric Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow -----16.90M17.30M25.72M30.55M26.99M37.07M39.22M27.98M44.13M46.81M
Investing Cash Flow ------31.84M-18.41M-17.18M-3.88M-185.59M-1.99M-305.23M-9.49M-81.31M-4.50M
Financing Cash Flow -----18.62M1.15M-9.02M-21.67M231.28M146.23M52.58M-33.33M32.84M-44.51M
Capital Expenditure --------2.80M-1.26M-1.50M-1.99M-4.43M-4.54M-2.57M-4.50M
Free Cash Flow -------22.92M29.29M25.49M35.08M34.79M23.44M41.57M42.31M
Net Change in Cash ------------213.43M-14.84M-4.34M-2.20M
Share Buybacks 105.00K597.00K102.00K22.00K-----------
Dividends Paid ---1.99M2.18M2.30M2.35M2.41M2.46M2.72M3.17M3.34M3.41M3.45M3.47M

Ratios (Annual)

Figures in %.

Metric Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Gross Margin % ------56.8%56.8%59.1%55.5%65.0%59.2%61.0%61.6%62.6%
Operating Margin % ------17.4%2.3%9.5%6.7%9.2%2.6%1.5%1.1%6.8%
Net Margin % ----------2.4%1.0%0.4%-117.6%-0.8%
ROE % ----------0.8%0.5%0.2%-174.9%-1.2%
ROCE % 24.3%26.9%21.4%13.5%15.5%11.9%10.5%1.5%7.3%2.1%2.2%0.7%0.5%0.6%6.1%

Shareholding Pattern

Insiders
5.44%
Institutions
93.52%
Public Float
98.90%

Top Institutional Holders

#Holder% HeldSharesValue
1 Long Path Partners LP 7.34% 405.58K $41.38M
2 Blackrock Inc. 7.13% 393.85K $40.18M
3 Boston Partners 4.86% 268.71K $27.41M
4 Select Equity Group LP 4.27% 235.88K $24.06M
5 Vanguard Capital Management LLC 4.21% 232.64K $23.73M
6 Ranger Investment Management, L.p. 3.67% 202.90K $20.70M
7 AQR Capital Management, LLC 3.09% 170.56K $17.40M
8 Morgan Stanley 2.93% 162.12K $16.54M
9 Royce & Associates LP 2.92% 161.23K $16.45M
10 Diamond Hill Capital Management Inc 2.81% 155.30K $15.84M

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for MLAB

No recent headlines available.

Explore More

📊 Technology Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks